1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, 7-(6-(ACETYLAMINO)-3-AZABICYCLO(3.1.0)HEX-3-YL)-1-(2,4-DIFLUOROPHENYL)-6-FLUORO-1,4-DIHYDRO-4-OXO-, (1.ALPHA.,5.ALPHA.,6.ALPHA.)-
UNII 0RAV43SV0Q
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,8-naphthyridine-3-carboxylic Acid, 7-(6-(acetylamino)-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, (1.alpha.,5.alpha.,6.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0RAV43SV0Q.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 175426-02-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H17F3N4O4 CMOSICBJHWQANO-MCBXIFIFSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,8-naphthyridine-3-carboxylic Acid, 7-(6-(acetylamino)-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, (1.alpha.,5.alpha.,6.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.